Close

Form 3 BOSTON SCIENTIFIC CORP For: Jul 01 Filed by: Butcher Arthur C

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. META
6. BA
7. IBM
8. V
9. KMB
10. SPY


July 6, 2016 4:19 PM EDT
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Butcher Arthur C
(Last) (First) (Middle)
300 BOSTON SCIENTIFIC WAY
(Street)
MARLBOROUGH MA 01752-1234
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2016 		3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP&Pres, Endoscopy
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,425
D
 
Common Stock 2,567 (1)
I
By 401(k)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units 02/22/2021 (2) 02/22/2021 (2) Common Stock 5,069 (3) (4) D  
Deferred Stock Units 02/23/2020 (5) 02/23/2020 (5) Common Stock 4,292 (6) (4) D  
Deferred Stock Units 02/24/2019 (7) 02/24/2019 (7) Common Stock 4,014 (8) (4) D  
Deferred Stock Units 02/27/2017 (9) 02/27/2017 (9) Common Stock 2,548 (10) (4) D  
Deferred Stock Units 02/28/2018 (11) 02/28/2018 (11) Common Stock 6,766 (12) (4) D  
Deferred Stock Units 06/01/2021 (13) 06/01/2021 (13) Common Stock 8,806 (14) (4) D  
Stock Option (Right to Buy)   (15) 02/28/2021 Common Stock 19,099 7.16 D  
Stock Option (Right to Buy)   (16) 02/24/2024 Common Stock 17,500 13.08 D  
Stock Option (Right to Buy)   (17) 02/23/2025 Common Stock 16,233 16.31 D  
Stock Option (Right to Buy)   (18) 02/22/2026 Common Stock 16,143 17.26 D  
Stock Option (Right to Buy)   (19) 06/01/2026 Common Stock 25,412 22.71 D  
Explanation of Responses:
1. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
2. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
3. This amount represents the unvested portion of DSUs awarded on February 22, 2016, which will continue to vest in five remaining installments on the anniversary of the date of grant
4. Each DSU represents the Company's commitment to issue one share of Boston Scientific common stock.
5. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
6. This amount represents the unvested portion of DSUs awarded on February 23, 2015, which will continue to vest in four remaining installment on the anniversary of the date of grant.
7. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
8. This amount represents the unvested portion of DSUs awarded on February 24, 2014, which will continue to vest in three remaining installment on the anniversary of the date of grant.
9. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant
10. This amount represents the unvested portion of DSUs awarded on February 27, 2012, which will continue to vest in one remaining installment on the anniversary of the date of grant.
11. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
12. This amount represents the unvested portion of DSUs awarded on February 28, 2013, which will continue to vest in two remaining installments on the anniversary of the date of grant.
13. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.
14. This amount represents the unvested portion of DSUs awarded on June 1, 2016, which will continue to vest in five remaining installment on the anniversary of the date of grant.
15. Grant to the reporting person of an option to purchase 19,099 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant
16. Grant to the reporting person of an option to purchase 17,500 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
17. Grant to the reporting person of an option to purchase 16,233 shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
18. Grant to the reporting person of an option to purchase 16,143 shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
19. Grant to the reporting person of an option to purchase 25,412 shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.
Remarks:
butcherpoa.txt
/s/ Lee G. Giguere, Attorney-in-Fact 07/06/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

	Know all by these present that the undersigned hereby constitutes and 
appoints each of Timothy A. Pratt, Vance R. Brown, Scott G. Hodgdon, Lee G.
Giguere
and Ashley E. McGrane signing singly, the undersigned's true and lawful
attorney-in-fact to:

(1)	execute for and on behalf of the undersigned, in the undersigned's
capacity as an executive officer and/or director of Boston Scientific 
Corporation 
(the "Company"), Forms 3, 4 and 5, and amendments thereto, in accordance with 
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)	do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4 
or 5
and file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; 

(3)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or director of the Company, Forms 144 in accordance
with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules
and regulations thereunder; and
	
(4)	take any other action of any type whatsoever in connection with the 
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, 
in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever 
requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or 
revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the Securities
Act of 1933, as amended.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this  27th day of June, 2016.


/s/ Arthur C. Butcher
________________							 
Arthur C. Butcher

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings